Takasugi N - Search Results

1

Osteoprotegerin and bone mineral density in hemodialysis patients.

Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N. Nakashima A, et al. Among authors: takasugi n. Osteoporos Int. 2006;17(6):841-6. doi: 10.1007/s00198-005-0047-0. Epub 2006 Apr 7. Osteoporos Int. 2006. PMID: 16604298

2

C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis.

Okumoto S, Taniguchi Y, Nakashima A, Masaki T, Ito T, Ogawa T, Takasugi N, Kohno N, Yorioka N. Okumoto S, et al. Among authors: takasugi n. Ther Apher Dial. 2009 Jun;13(3):205-12. doi: 10.1111/j.1744-9987.2009.00658.x. Ther Apher Dial. 2009. PMID: 19527467

3

Vitamin K₂ alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level.

Ochiai M, Nakashima A, Takasugi N, Kiribayashi K, Kawai T, Usui K, Shigemoto K, Hamaguchi N, Kohno N, Yorioka N. Ochiai M, et al. Among authors: takasugi n. Nephron Clin Pract. 2011;117(1):c15-9. doi: 10.1159/000319642. Epub 2010 Aug 3. Nephron Clin Pract. 2011. PMID: 20689320 Clinical Trial.

4

Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.

Sugiya N, Nakashima A, Takasugi N, Kawai A, Kiribayashi K, Tanaka J, Kohno N, Yorioka N. Sugiya N, et al. Among authors: takasugi n. Osteoporos Int. 2011 May;22(5):1573-9. doi: 10.1007/s00198-010-1350-y. Epub 2010 Jul 22. Osteoporos Int. 2011. PMID: 20652228

5

Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.

Nakashima A, Carrero JJ, Qureshi AR, Hirai T, Takasugi N, Ueno T, Taniguchi Y, Lindholm B, Yorioka N. Nakashima A, et al. Among authors: takasugi n. Osteoporos Int. 2011 Jun;22(6):1695-701. doi: 10.1007/s00198-010-1377-0. Epub 2010 Sep 2. Osteoporos Int. 2011. PMID: 20812007

6

Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients: a prospective study.

Asakimori Y, Yorioka N, Tanaka J, Takasugi N, Harada S, Shigemoto K, Yamashita K, Usui K, Arita M, Kohno N. Asakimori Y, et al. Among authors: takasugi n. Am J Kidney Dis. 2004 Jul;44(1):112-20. doi: 10.1053/j.ajkd.2004.03.034. Am J Kidney Dis. 2004. PMID: 15211444

7

Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.

Nakashima A, Yorioka N, Mizutani T, Yamagata Z, Ueno T, Takasugi N. Nakashima A, et al. Among authors: takasugi n. Nephron Clin Pract. 2005;99(3):c78-85. doi: 10.1159/000083418. Epub 2005 Jan 19. Nephron Clin Pract. 2005. PMID: 15665550

8

Switching from epoetin alpha to darbepoetin alpha in Japanese hemodialysis patients: dose conversion ratio.

Hirai T, Sugiya N, Nakashima A, Takasugi N, Yorioka N. Hirai T, et al. Among authors: takasugi n. Nephron Clin Pract. 2009;111(2):c81-6. doi: 10.1159/000183843. Epub 2008 Dec 17. Nephron Clin Pract. 2009. PMID: 19088483

9

Response of secondary hyperparathyroidism to cinacalcet depends on parathyroid size.

Hirai T, Nakashima A, Takasugi N, Yorioka N. Hirai T, et al. Among authors: takasugi n. Nephron Clin Pract. 2010;114(3):c187-93. doi: 10.1159/000262301. Epub 2009 Nov 28. Nephron Clin Pract. 2010. PMID: 19955824 Clinical Trial.

10

Dose conversion ratio one year after switching from epoetin alpha to darbepoetin alpha in Japanese hemodialysis patients.

Hirai T, Nakashima A, Shiraki N, Takasugi N, Yorioka N. Hirai T, et al. Among authors: takasugi n. Int J Artif Organs. 2010 May;33(5):283-9. Int J Artif Organs. 2010. PMID: 20593349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters